Shijiazhuang Yiling Pharmaceutical Co Ltd Total Liabilities
Shijiazhuang Yiling Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) has total liabilities worth CN¥3.08 Billion CNY (≈ $450.79 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 002603 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Shijiazhuang Yiling Pharmaceutical Co Ltd (2008–2025)
Total liabilities of Shijiazhuang Yiling Pharmaceutical Co Ltd from 2008 to 2025. This chart illustrates how Shijiazhuang Yiling Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Shijiazhuang Yiling Pharmaceutical Co Lt (002603) long-term investment share to see how much of total assets are deployed in long-term investments.
Shijiazhuang Yiling Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Shijiazhuang Yiling Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
VisEra Technologies Co. Ltd.
TW:6789
|
Taiwan | NT$4.20 Billion |
|
Independent Bank
NASDAQ:INDB
|
USA | $21.46 Billion |
|
BBB Foods Inc.
NYSE:TBBB
|
USA | $22.83 Billion |
|
Tango Therapeutics Inc
NASDAQ:TNGX
|
USA | $49.35 Million |
|
Axiata Group Bhd
KLSE:6888
|
Malaysia | RM25.54 Billion |
|
Carnival Corporation & plc
F:POH1
|
Germany | €38.52 Billion |
|
Jointown Pharmaceutical Group Co Ltd
SHG:600998
|
China | CN¥77.21 Billion |
|
Marriot Vacations Worldwide
NYSE:VAC
|
USA | $7.42 Billion |
Liability Composition Analysis (2008–2025)
This chart breaks down Shijiazhuang Yiling Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Shijiazhuang Yiling Pharmaceutical Co Lt total assets.
Liquidity & Leverage Metrics
Shijiazhuang Yiling Pharmaceutical Co Ltd Total Liabilities Ratios Explained
Shijiazhuang Yiling Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.20 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.28 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shijiazhuang Yiling Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shijiazhuang Yiling Pharmaceutical Co Ltd (2008–2025)
The table below shows the annual total liabilities of Shijiazhuang Yiling Pharmaceutical Co Ltd from 2008 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥2.69 Billion ≈ $394.09 Million |
-13.60% |
| 2024-12-31 | CN¥3.12 Billion ≈ $456.13 Million |
-43.75% |
| 2023-12-31 | CN¥5.54 Billion ≈ $810.87 Million |
+2.42% |
| 2022-12-31 | CN¥5.41 Billion ≈ $791.73 Million |
+41.17% |
| 2021-12-31 | CN¥3.83 Billion ≈ $560.84 Million |
+48.28% |
| 2020-12-31 | CN¥2.58 Billion ≈ $378.24 Million |
+131.44% |
| 2019-12-31 | CN¥1.12 Billion ≈ $163.43 Million |
+12.41% |
| 2018-12-31 | CN¥993.56 Million ≈ $145.39 Million |
+28.11% |
| 2017-12-31 | CN¥775.58 Million ≈ $113.49 Million |
-16.16% |
| 2016-12-31 | CN¥925.04 Million ≈ $135.36 Million |
+5.17% |
| 2015-12-31 | CN¥879.56 Million ≈ $128.71 Million |
+31.04% |
| 2014-12-31 | CN¥671.19 Million ≈ $98.22 Million |
+67.93% |
| 2013-12-31 | CN¥399.69 Million ≈ $58.49 Million |
+24.61% |
| 2012-12-31 | CN¥320.75 Million ≈ $46.94 Million |
-38.76% |
| 2011-12-31 | CN¥523.78 Million ≈ $76.64 Million |
-22.98% |
| 2010-12-31 | CN¥680.08 Million ≈ $99.52 Million |
-5.40% |
| 2009-12-31 | CN¥718.89 Million ≈ $105.20 Million |
+106.65% |
| 2008-12-31 | CN¥347.88 Million ≈ $50.91 Million |
-- |
About Shijiazhuang Yiling Pharmaceutical Co Ltd
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine in China and internationally. It offers dietary supplements, and healthy food and drinks; patent TCM products for respiratory health, cardiovascular disease, diabetes, mellitus, oncology, urologic disease, sleep-improving, and anti-aging; disinfection and pers… Read more